MyAverix Finance
HK · Healthcare
Shanghai Junshi Biosciences Co Ltd (1877)
Biotechnology
Shanghai Junshi Biosciences Co Ltd (1877) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $24.46B, P/E ratio is 18.00, net margin is -24.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1877
Shanghai Junshi Biosciences Co Ltd (1877) — FAQ
What is Shanghai Junshi Biosciences Co Ltd's market cap?
Shanghai Junshi Biosciences Co Ltd (1877) has a reported market cap of $24.46B (data as of 2026-05-21).
What is 1877's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Junshi Biosciences Co Ltd (1877) is 18.00 (data as of 2026-05-21).
Does Shanghai Junshi Biosciences Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Junshi Biosciences Co Ltd (1877). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Junshi Biosciences Co Ltd in?
Shanghai Junshi Biosciences Co Ltd (1877) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1877 listed on?
1877 is listed on HK.
What is Shanghai Junshi Biosciences Co Ltd's net margin?
Shanghai Junshi Biosciences Co Ltd (1877) reports a net margin of -24.3% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.